A greater proportion of anti-TNF-treated patients in our cohort were bDMARD-naïve patients, suggesting they might have a more rapid reduction in disease activity and greater improvements in physical function related to active RA in comparison with bDMARD-experienced patients [21]. Here, TNF is linked to rheumatoid arthritis.